Navigation Links
New P.E. Drug Approved In Europe While Premature Ejaculation Cure Remains Out of Reach to American Men
Date:4/3/2009

Demand for one of the leading, anti-premature ejaculation formulas is expected to soar after regulatory approvals for the first medicine for premature ejaculation are granted outside of the United States.

Los Angeles, CA (PRWEB) April 3, 2009 -- American men who eagerly await an FDA approved premature ejaculation pill will find no relief from the overseas approval of dapoxetine. Marketed under the brand name Priligy™, dapoxetine has been approved for medical use in Sweden and Finland, but was rejected for use at this time by the U.S. Federal Drug Administration.

"The need remains to develop libido products that are suitable alternatives to drugs and not only help men last longer and offer the chance at healthy, satisfying sex lives, but are safe and detached of potentially harmful side effects," stated W. Baclini, founder of one of the most respected manufacturers of male health and performance supplements, Zurich Medical Labs in Los Angeles, California.

An estimated 30 million adult men in the United States endure problems with premature ejaculation, a condition thought to affect up to 30% of the male population worldwide. Health experts attribute lack of climax control to low levels of naturally produced brain chemical, serotonin. This important 'feel-good' neurotransmitter is responsible for regulating mood and mental faculties, promoting proper nervous system function and helps prolong orgasm.

Dapoxetine is among a class of selective serotonin reuptake inhibitor (SSRI) drugs that include antidepressants which are widely used to stimulate production of serotonin to last longer in bed. Major drug intolerances including nausea, headaches, diarrhea and dizziness are associated with SSRIs leaving many men tentative about using them to stop premature ejaculation.

"The problem isn't just that this kind of artificial solution for premature ejaculation cure remains inaccessible in the U.S., it's the inherent risks tied to this solution for how to last longer in bed," adds Baclini. Only a fragment of men who experience lack of climax control seek help for this distressing problem that can disrupt personal relationships and intimacy.

Responding to the unmet need for an effective, scientifically proven home remedy for quick climax, Zurich Medical Labs developed Prematrol as a safe, drug-free approach to help achieve better control and male sexual health. Prematrol uses an advanced blend of naturally potent ingredients known to influence serotonin and believed to prolong orgasm.

Amidst a sea of untested libido products that must be taken before intercourse and arguably deter spontaneity, Prematrol works steadily and consistently to prepare the male body for sexual activity when desired. Known for quality and efficacy amongst its users, Prematrol is safe for everyday use and nutritionally formulated to aid overall male health including cardiovascular support and sleep cycles while supporting healthy sexual function. The ingredients in Prematrol have substantial scientific data and seem to:

  • Support firm erections
  • Slow down orgasm until ready
  • Support climax control
  • Increase sexual confidence
  • Enhance couples intimacy

Already used by thousands of men for longer lasting intercourse, Prematrol is in high demand and retains its footing as one of the most sought-after nutritional solutions for how to last longer in bed. Prematrol is endorsed by sexual dysfunction health expert, Dr. Ramnanan, who has incorporated Prematrol into his clinic's treatment plans with astounding success.

Available nationwide without physician consultation through www.prematrol4men.com and selective U.S. retailers, Prematrol will soon be available in many European countries due to overwhelming popularity.

Men are invited to visit www.prematrol4men.com to learn about the science behind Prematrol and take advantage of a special limited time offer.

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2257934.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. FEW Salutes House for Passing Legislation with Federal Worker Provisions; FERS Sick Leave Credit and FERS Redeposit Approved
2. FDA Warns Drug Makers to Stop Selling Unapproved Prescription Painkillers
3. IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer
4. Immune-based drug approved in Europe for pediatric cancer patients
5. United States Files Suit Against Missouri-Based Pharmaceutical to Block Manufacturing and Shipping of Unapproved Drugs
6. Newly Published Menopause Study: Bioidentical and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
7. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
8. Shengtai Pharmaceutical, Inc. Comments on Chinas Recently Approved Health Care Reform Plan
9. Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
10. A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009
11. CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Clarion Safety Systems ... safety labels , has been featured in the National Electrical Manufacturers Association’s (NEMA) ... provides electroindustry professionals with manufacturer, regulatory, and standardization news. The publication is a ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers from Catholic ... designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The data, presented ... in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event rates over ...
(Date:5/24/2016)... ... May 24, 2016 , ... Applications ... multiplex immunoassays are widely used for cell and protein analysis. Keeping updated on ... quality and efficiency in these areas. , LabRoots introduces a new complementary ...
(Date:5/23/2016)... ... ... Edward D. Buckingham, M.D . is excited announce that he has been ... out by the National Consumer Advisory Board to honor excellence in medicine. Only doctors ... award. , The National Consumer Advisory Board (NCAB) is a private organization created to ...
(Date:5/23/2016)... TX (PRWEB) , ... May 23, 2016 , ... ... to announce the participation of high-level representatives from the Japan PMDA, US FDA, ... discussions will address how CDISC standards help format data from clinical trials so ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Een app die artsen over ... patiënten kunnen behandelen, hun kennis kunnen delen en van ... nieuwe en revolutionaire MDLinking App, ontwikkeld door een internationale ... Hans Flu en oncologisch chirurg dr. Gijs van ... wordt op dinsdag 24 mei officieel gepresenteerd op het ...
(Date:5/23/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today the ... The hands-on learning experience is a 12-week summer program, ... Fellowship and Internship programs bring participants ... interns are provided optional housing free of charge through ... the Riverfront Residence Hall to foster communication and collaboration ...
(Date:5/23/2016)... , May 23, 2016 ... Devices, Diagnostics and Monitoring, and Vision Care ... Which areas are going to grow at the fastest ... revenues to 2026, assessing data, trends, opportunities and prospects. ... charts, and graphs. Discover the most lucrative areas in ...
Breaking Medicine Technology: